Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.3% | −2.1% | −5.4% | −7.9% | — | — | — | — | +3.3% |
| Peer average | −1.6% | −1.2% | −2.0% | −3.8% | +10.5% | +12.9% | +66.6% | +51.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$85 of every $1,000 in SQS is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 8.45% | $845.25 | 316K | $112.5M |
| 2 | MSFTMicrosoft | Technology | 7.39% | $738.85 | 188K | $98.3M |
| 3 | NVDANvidia | Technology | 7.30% | $730.06 | 597K | $97.2M |
| 4 | LLYEli Lilly | Healthcare | 6.30% | $629.97 | 58K | $83.8M |
| 5 | AMZNAmazon | Consumer Cyclical | 5.94% | $593.68 | 296K | $79.0M |
| 6 | GOOGLAlphabet | Communication Services | 5.71% | $571.14 | 257K | $76.0M |
| 7 | AVGOBroadcom | Technology | 3.97% | $397.34 | 152K | $52.9M |
| 8 | JPMJpmorgan Chase | Financial Services | 3.44% | $343.92 | 132K | $45.8M |
| 9 | MUMicron Technology | Technology | 3.43% | $343.46 | 59K | $45.7M |
| 10 | ASNDAscendis Pharma A/S | Healthcare | 2.93% | $292.52 | 141K | $38.9M |
| 11 | METAMETA Platforms | Communication Services | 2.90% | $290.42 | 60K | $38.6M |
| 12 | PANWPalo Alto Networks | Technology | 2.37% | $236.62 | 98K | $31.5M |
| 13 | JNJJohnson & Johnson | Healthcare | 2.27% | $227.30 | 106K | $30.3M |
| 14 | CVXChevron | Energy | 2.24% | $224.44 | 136K | $29.9M |
| 15 | CBOECBOE Global Markets | Financial Services | 2.21% | $220.84 | 78K | $29.4M |
Not enough history yet: SQS needs a year of prices.
SQS does not pay a distribution.
of the $167B in 60 Factor ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 8.45% |
| 2 | MSFT | Microsoft | 7.39% |
| 3 | NVDA | Nvidia | 7.30% |
| 4 | LLY | Eli Lilly & | 6.30% |
| 5 | AMZN | Amazon | 5.94% |
| 6 | GOOGL | Alphabet | 5.71% |
| 7 | AVGO | Broadcom | 3.97% |
| 8 | JPM | Jpmorgan Chase & | 3.44% |
| 9 | MU | Micron Technology | 3.43% |
| 10 | ASND | Ascendis Pharma A/S | 2.93% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]